These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 22534554)

  • 1. Risk of contrast induced nephropathy in the critically ill: a prospective, case matched study.
    Cely CM; Schein RM; Quartin AA
    Crit Care; 2012 Dec; 16(2):R67. PubMed ID: 22534554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of N-acetylcysteine and ascorbic acid in contrast-induced nephropathy in critical care patients: an open-label randomized controlled study.
    Palli E; Makris D; Papanikolaou J; Garoufalis G; Tsilioni I; Zygoulis P; Zakynthinos E
    Crit Care; 2017 Oct; 21(1):269. PubMed ID: 29089038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The risk of radiocontrast nephropathy in patients with cirrhosis.
    Najjar M; Hamad A; Salameh M; Agarwal A; Feinfeld DA
    Ren Fail; 2002 Jan; 24(1):11-8. PubMed ID: 11921694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prophylactic hydration to protect renal function from intravascular iodinated contrast material in patients at high risk of contrast-induced nephropathy (AMACING): a prospective, randomised, phase 3, controlled, open-label, non-inferiority trial].
    Nijssen EC; Rennenberg RJ; Nelemans PJ; Essers BA; Janssen MM; Vermeeren MA; van Ommen V; Wildberger JE
    Ned Tijdschr Geneeskd; 2018; 161():D1734. PubMed ID: 29328007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Failure to demonstrate contrast nephrotoxicity.
    Heller CA; Knapp J; Halliday J; O'Connell D; Heller RF
    Med J Aust; 1991 Sep; 155(5):329-32. PubMed ID: 1895978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contrast-induced nephropathy risk due to emergency contrast-enhanced computed tomography.
    Durukan P; Ozkan S; Ikizceli I; Vardar A; Ipekci A; Duman A
    Eur J Emerg Med; 2012 Feb; 19(1):20-3. PubMed ID: 21552131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrast-induced nephropathy in aged critically ill patients.
    Palli E; Makris D; Papanikolaou J; Garoufalis G; Zakynthinos E
    Oxid Med Cell Longev; 2014; 2014():756469. PubMed ID: 24672639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contrast-induced nephropathy: attributable incidence and potential harm.
    Pires de Freitas do Carmo L; Macedo E
    Crit Care; 2012 May; 16(3):127. PubMed ID: 22621609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Balancing the risks and benefits of using emergency diagnostic radiocontrast studies to diagnose life-threatening illness in critically ill patients: a decision analysis.
    Ho KM
    Anaesth Intensive Care; 2016 Nov; 44(6):724-728. PubMed ID: 27832559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylactic hydration to protect renal function from intravascular iodinated contrast material in patients at high risk of contrast-induced nephropathy (AMACING): a prospective, randomised, phase 3, controlled, open-label, non-inferiority trial.
    Nijssen EC; Rennenberg RJ; Nelemans PJ; Essers BA; Janssen MM; Vermeeren MA; Ommen VV; Wildberger JE
    Lancet; 2017 Apr; 389(10076):1312-1322. PubMed ID: 28233565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of radiocontrast-media-induced nephropathy in patients with pre-existing renal insufficiency by hydration in combination with the adenosine antagonist theophylline.
    Erley CM; Duda SH; Rehfuss D; Scholtes B; Bock J; Müller C; Osswald H; Risler T
    Nephrol Dial Transplant; 1999 May; 14(5):1146-9. PubMed ID: 10344353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nephropathy in critically Ill patients without preexisting renal disease.
    Polena S; Yang S; Alam R; Gricius J; Gupta JR; Badalova N; Chuang P; Gintautas J; Conetta R
    Proc West Pharmacol Soc; 2005; 48():134-5. PubMed ID: 16416679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective study of the incidence of contrast-induced nephropathy among patients evaluated for pulmonary embolism by contrast-enhanced computed tomography.
    Mitchell AM; Jones AE; Tumlin JA; Kline JA
    Acad Emerg Med; 2012 Jun; 19(6):618-25. PubMed ID: 22687176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive value of the RIFLE urine output criteria on contrast-induced nephropathy in critically ill patients.
    Hocine A; Defrance P; Lalmand J; Delcour C; Biston P; Piagnerelli M
    BMC Nephrol; 2016 Mar; 17():36. PubMed ID: 27021438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors affecting the incidence of contrast-induced nephropathy in patients undergoing computed tomography.
    Heras Benito M; Garrido Blázquez M; Gómez Sanz Y; Bernardez Mardomingo M; Ruiz Cacho J; Rodríguez Recio FJ; Fernández-Reyes Luis MJ
    Radiologia (Engl Ed); 2018; 60(4):326-331. PubMed ID: 29779857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of cystatin C and serum creatinine for the diagnosis of contrast-induced nephropathy in patients undergoing contrast-enhanced computed tomography at an oncology centre.
    Fortalesa Melo JI; Chojniak R; Costa Silva DH; Oliveira Junior JC; Vieira Bitencourt AG; Holanda Silva D; Guimarães MD; Silva HC; Dias DG; Rodrigues WC; Brancucci EL; Cruz BM; Schiavon BN; Argenton JL; Camporini MA; Zocchio A
    PLoS One; 2015; 10(5):e0122877. PubMed ID: 25961558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography.
    Manske CL; Sprafka JM; Strony JT; Wang Y
    Am J Med; 1990 Nov; 89(5):615-20. PubMed ID: 2239981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probability of reduced renal function after contrast-enhanced CT: a model based on serum creatinine level, patient age, and estimated glomerular filtration rate.
    Herts BR; Schneider E; Obuchowski N; Poggio E; Jain A; Baker ME
    AJR Am J Roentgenol; 2009 Aug; 193(2):494-500. PubMed ID: 19620448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylaxis of contrast material-induced nephropathy in patients in intensive care: acetylcysteine, theophylline, or both? A randomized study.
    Huber W; Eckel F; Hennig M; Rosenbrock H; Wacker A; Saur D; Sennefelder A; Hennico R; Schenk C; Meining A; Schmelz R; Fritsch R; Weiss W; Hamar P; Heemann U; Schmid RM
    Radiology; 2006 Jun; 239(3):793-804. PubMed ID: 16714461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of contrast-induced nephropathy by N-acetylcysteine in critically ill patients: different definitions, different results.
    Chousterman BG; Bouadma L; Moutereau S; Loric S; Alvarez-Gonzalez A; Mekontso-Dessap A; Laissy JP; Rahmouni A; Katsahian S; Brochard L; Schortgen F
    J Crit Care; 2013 Oct; 28(5):701-9. PubMed ID: 23683568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.